Indatuximab Biosimilar: A New Frontier in CD138-Targeted Cancer Therapy Indatuximab ravtansine is a CD138-targeting antibody-drug conjugate (ADC) designed for … read more 4th Dec 2024 Shanza Riaz
Vopratelimab Biosimilar: A Next-Generation ICOS Agonist for Cancer Immunotherapy Vopratelimab is a monoclonal antibody targeting inducible T-cell costimulator (ICOS), … read more 4th Dec 2024 Shanza Riaz
CB6 Biosimilar: Targeting SARS-CoV-2 with Cost-Effective Monoclonal Antibody Therapy CB6, also known as Etesevimab, is a monoclonal antibody that targets the receptor-bind … read more 4th Dec 2024 Shanza Riaz
